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Abstract
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Critique of:
Citation
Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R: Mor-
tality related to severe sepsis and septic shock among critically 
ill patients in Australia and New Zealand, 2000–2012. JAMA 
2014, 311(13):13081316.
Background
Severe sepsis and septic shock are major causes of mortality in 
intensive care unit (ICU) patients. This study analyzed changes 
in incidence of severe sepsis and septic shock over time (2000 to 
2012) in ICU’s across New Zealand and Australia. The study also 
analyzed mortality rate and discharge to home for these patients. 
Analysis was made using international consensus conference defi-
nitions for severe sepsis, objective definitions of acute organ failure 
and sensitivity analysis. Authors further used APACHE III scores, 
treatment facility type and location, age and source and type of 
infection to further analyze the data.
Methods
The authors studied all patients (101,064) with severe sepsis during 
the time period from January 1, 2000 through December 31, 2012 
in Australia and New Zealand. All hospital outcomes were analyzed 
including mortality, discharge to rehabilitation, discharge home and 
discharge to other hospital at 30 days. Subgroup analysis was per-
formed on said patients to include severe sepsis and septic shock, 
APACHE II or APACHE III scores, operative admission, medical 
admission, renal failure, respiratory failure, age groups, sepsis with 
or without shock source urinary in nature and sepsis with or without 
shock source non-urinary in nature.
Objective
To describe changes in mortality for severe sepsis with and without 
shock in adult ICU patients. To assess and trend number of severe 
sepsis cases per year. Subgroup analyses were planned in younger 
patient’s (<45 yrs), UTI vs. other causes, surgical vs. medical 
patients and patients by APACHE scores.
Design
Retrospective, observational study.
Setting
Over 90% of adult ICU admissions with severe sepsis in Australia 
and New Zealand from January 1, 2000 to December 31, 2012.
Subjects
Adult ICU patients, within 24 hours of admission, in Australia and 
New Zealand obtained via the Australian and New Zealand Intensive 
Care Society adult ICU patient database. The human research ethics 
committee of Alfred Hospital provided approval of this study.
Analysis
Logistic regression was used to account for incidence changes 
of severe sepsis over the studied time period. Further logistic 
regression was used to associate admission year, APACHE scores 
and locations with outcomes to ensure that the data was robust over 
years and locations. Finally, sensitivity analysis was performed to 
ensure consistency of results by studying a subpopulation of 63 
hospitals that had data for the entire time period and showing simi-
larities in outcomes.
Results
Absolute mortality in severe sepsis decreased from 35.0% (95%CI, 
33.2%-36.8%; 949/2708) to 18.4% (95% CI, 17.8%-19.0%; 2300/12 
512; P <0 .001), representing an overall decrease of 16.7% (95% 
CI, 14.8%-18.6%), an annual rate of absolute decrease of 1.3%, and 
a relative risk reduction of 47.5% (95% CI, 44.1%-50.8%). After 
adjusted analysis, mortality decreased throughout the study period 
with an odds ratio (OR) of 0.49 (95% CI, 0.46-0.52) in 2012, using 
the year 2000 as the reference (P < .001). The annual decline in 
mortality did not differ significantly between patients with severe 
sepsis and those with all other diagnoses (OR, 0.94 [95% CI, 0.94-
0.95] vs 0.94 [95% CI, 0.94-0.94]; P = .37). The annual increase in 
rates of discharge to home was significantly greater in patients with 
severe sepsis compared with all other diagnoses (OR, 1.03 [95% CI, 
1.02-1.03] vs 1.01 [95% CI, 1.01-1.01]; P <0 .001). Conversely, the 
annual increase in the rate of patients discharged to rehabilitation 
facilities was significantly less in severe sepsis compared with all 
other diagnoses (OR, 1.08 [95% CI, 1.07-1.09] vs 1.09 [95% CI, 
1.09-1.10]; P < .001). In the absence of comorbidities and older 
age, mortality was less than 5%.
Conclusions
In critically ill patients in Australia and New Zealand with severe 
sepsis with and without shock, there was a decrease in mortality 
from 2000 to 2012. These findings were accompanied by changes 
in the patterns of discharge to home, rehabilitation and other 
hospitals.
Abstract adapted from the original provided courtesy of PubMed: 
A service of the National Library of Medicine and the National 
Institutes of Health.
Commentary
True rates of sepsis and mortality from sepsis have remained elusive. 
In the past, studies have looked at sepsis incidence, and estimations 
have been made that there are over 1 million sepsis patients in the 
US yearly as of 20121. Sepsis rates seem to be increasing based 
on recent studies2–4, with sepsis being ranked the most expensive 
reason for hospitalization in the US in 20115. Unfortunately, prior 
studies were plagued by coding problems and limitations in study 
population, as data was only partial representation of populations 
studied. This led to concerns that there were errors in obtain-
ing results and limitations of the data sets, leading to potential 
confounders.
The data set used in this study comprises over 90% of the ICU 
admissions in Australia and New Zealand. Admission diagnosis 
were screened for severe sepsis and studied over a 12-year period 
from 2000 to 2012. The primary outcomes studied were rates of 
severe sepsis and all hospital outcomes including mortality, dis-
charge to home, discharge to rehab and discharge to other hospitals. 
Subgroup analysis was performed to evaluate whether or not patient 
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differences during this time frame accounted for outcome differ-
ences. Results showed severe sepsis rates appeared to have increased 
over this time period from 2,700 patients in 2000 to 12,512 in 2012. 
This rise is surprisingly high and represents a large increase in 
incidence of disease. To this end, the authors identified causes of 
infection and used objective criteria to identify organ dysfunction. 
The data was studied using sensitivity analysis and, in particu-
lar, studied ICU’s that contributed data over all years, suggest-
ing increased incidence of severe sepsis. Furthermore, mortality 
appears to have decreased significantly from 35% to 18%. Sub-
groups were similar and discharge to home was markedly improved 
with severe sepsis patients and more patients went to rehab over 
this time period.
Strengths of this study include robustness of data set, comprising 
almost the entire ICU admissions in Australia and New Zealand. 
This is the only study to assess changes in mortality in septic 
patients, adjusted for APACHE score, over such a large time period. 
Additionally, this study data was prospectively collected, leading to 
less bias. This data set was robust to sensitivity analysis, implying 
accuracy of the conclusions of declining mortality with increasing 
severe sepsis patients.
There are a number of limitations to this study. The study only 
analyzed patients within the first 24 hours of ICU admission. It is 
possible that less sick patients (early sepsis diagnosis) are being 
counted and more ill patients (late sepsis diagnosis) are dying at 
increased rates. This is not a significant limitation as comparisons 
were being made across the 12 year study time period using the 
same definition such that the results reflect a temporal change by 
that standard. Hospital mortality was the only mortality reported. 
It is possible that patients are not doing better over a longer time 
period after discharge; however based on the large proportion of 
patients discharged to home this is unlikely. This study did not dif-
ferentiate etiologies of severe sepsis, and this may have accounted 
for changes in mortality. The accuracy of severe sepsis data col-
lection was also not monitored and the marked increase in severe 
sepsis rates begs the question whether increasing numbers of less 
sick patients are being admitted to the ICU. Arguing against this is 
the APACHE score adjustments which reflect do not reflect a drop 
in severity. Nonetheless the substantial increase in incidence over 
such a brief time is surprising and yet to be explained.
The Kaukonen et al.6 study is the largest, most robust study assessing 
sepsis incidence and outcomes to date. This study seems to strongly 
suggest that sepsis mortality is decreasing despite increases in sepsis 
rates. This would suggest that our care of sepsis is improving from 
both a diagnostic and therapeutic standpoint. Improved septic patients’ 
discharge to home suggests that severe sepsis patients are also 
having improved quality of life outcomes. Of note, recent prospective 
clinical trials in sepsis (ARISE7 and PROCESS8) have noted similar 
mortality rates to this study, corroborating declining sepsis rates.
Recommendation
This is an important epidemiological study that suggests that 
severe sepsis mortality has decreased significantly over time in the 
face of increased severe sepsis rates. This study further suggests 
that all critical care mortality appears to be declining. Patients with 
severe sepsis do seem to fare better as compared to other critical 
care illnesses based on increased home discharges. The declining 
rate of mortality has important implications in the design of future 
therapeutic trials targeting sepsis.
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